Correction to: npj Vaccines (2017). https://doi.org/10.1038/s41541-017-0027-3; Published 8 September 2017
In the original version of the article, Fig. 2b was mislabelled. The second row was incorrectly labelled as “MiMPL > MiPBS and MiQS ≈ MPBS” this has now been corrected to “MiQS-21 > MiPBS and MiMPL ≈ MiPBS”. The third row was incorrectly labelled as “MiQS21 > MiPBS and MiMPL ≈ MiPBS” this has now been corrected to “MiMPL > MiPBS and MiQS-21 ≈ MiPBS”. These errors have now been corrected in the PDF and HTML versions of this article.
A taxonomy of possible interplays between QS-21 and MPL in AS01 is shown. The conditions to be met for each category are represented in bold. Mi represents the gene expression level for each gene i. Numbers in italics represent the number of AS01 DEGs belonging to each category at 2 h, 4 h, and 6 h after immunization, respectively
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41541-017-0027-3.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Coccia, M., Collignon, C., Hervé, C. et al. Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity. npj Vaccines 3, 13 (2018). https://doi.org/10.1038/s41541-018-0047-7
Published:
DOI: https://doi.org/10.1038/s41541-018-0047-7
